Under-utilization of statins among people with HIV who were aged 40 years or older

Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/9024

Full metadata record

DC Field	Value	Language
dc.contributor.author	Wu, Pei-Ying	-
dc.contributor.author	Sun, Hsin-Yun	-
dc.contributor.author	Huang, Yu-Shan	-
dc.contributor.author	dkk.	-
dc.date.accessioned	2024-12-14T05:06:06Z	-
dc.date.available	2024-12-14T05:06:06Z	-
dc.date.issued	2024-02	-
dc.identifier.issn	1684-1182	-
dc.identifier.uri	http://localhost:8080/xmlui/handle/123456789/9024	-
dc.description.abstract	From June 2022 to April 2023, 1629 HIV-positive participants were assessed for the risk of atherosclerotic cardiovascular disease (ASCVD). The 10-year ASCVD risk of <5 %, 5 % to <7.5 %, 7.5 % to <20 % and 20 % were 59.9 %, 14.4 %, 20.7 % and 5.0 %, respectively; 440 (27.0 %) participants met the criteria for statin therapy, but only 171 (38.8 %) were prescribed statins.	en_US
dc.language.iso	en_US	en_US
dc.publisher	Journal of Microbiology, Immunology and Infection	en_US
dc.relation.ispartofseries	Short Communication;200-203	-
dc.subject	Lipid-lowering agent	en_US
dc.subject	Dyslipidemia	en_US
dc.subject	Major adverse cardiovascular event	en_US
dc.subject	Atherosclerotic cardiovascular disease	en_US
dc.subject	Diabetes mellitus	en_US
dc.subject	Non-communicable disease	en_US
dc.title	Under-utilization of statins among people with HIV who were aged 40 years or older	en_US
dc.type	Article	en_US
Appears in Collections:	Vol. 57 No. 1 (2024)

Files in This Item:

File	Description	Size	Format
200-203.pdf		365.07 kB	Adobe PDF	View/Open

DSpace JSPUI